Index by author

June 01, 2025; Volume 92,Issue 6

  1. Mandell, Brian F.

    1. Allopurinol hypersensitivity is rare, bad, and partially avoidable, but allopurinol can still be used effectively
      Brian F. Mandell, MD, PhD
      Cleveland Clinic Journal of Medicine June 2025, 92 (6) 326-328; DOI: https://doi.org/10.3949/ccjm.92b.06025

      The shadow of the 1984 Hande et al guidelines still hangs over clinical decision-making when managing allopurinol dosing in patients with gout and chronic kidney disease.

  2. Narechania, Shraddha

    1. Should I start anticoagulation in my patient newly diagnosed with pulmonary hypertension?
      Tark Abou-Elmagd, MD, MSc, MBBCh and Shraddha Narechania, MD
      Cleveland Clinic Journal of Medicine June 2025, 92 (6) 339-343; DOI: https://doi.org/10.3949/ccjm.92a.24083

      The decision hinges on the subtype of pulmonary hypertension the patient has.

  3. Pattacini, Corrado

    1. Severe cutaneous reaction induced by allopurinol
      Pietro Bocchi, MD, Lorenza Terroni, MD and Corrado Pattacini, MD
      Cleveland Clinic Journal of Medicine June 2025, 92 (6) 331-333; DOI: https://doi.org/10.3949/ccjm.92a.24063

      Three weeks after starting allopurinol for gout, an 86-year-old woman presented with a maculopapular rash and painful blistering and erosions of the oral mucosa.

  4. Ramsawak, Seshma

    1. IgA nephropathy: Update on pathogenesis and treatment
      IgA nephropathy: Update on pathogenesis and treatment
      Seshma Ramsawak, MD, Scott Cohen, MD, Andrea Linares, DO and Corey Cavanaugh, DO
      Cleveland Clinic Journal of Medicine June 2025, 92 (6) 373-383; DOI: https://doi.org/10.3949/ccjm.92a.24105

      Renin-angiotensin-aldosterone system inhibitors or corticosteroids remain the cornerstone of therapy, but new agents targeting the different “hits” in the pathogenesis of IgA nephropathy are being introduced.

  5. Saati, Ammar

    1. Direct oral anticoagulants: Challenging prescribing scenarios in everyday practice
      CME article
      Syed Bukhari, MD, MHA, Mohamed Ghoweba, MD, Syed Zamrak Khan, MD, Ammar Saati, MD and Marcelo Gomes, MD
      Cleveland Clinic Journal of Medicine June 2025, 92 (6) 353-361; DOI: https://doi.org/10.3949/ccjm.92a.24061

      Preapproval trials of direct oral anticoagulants excluded patients with extreme body weight and advanced kidney and liver disease and those who had undergone bariatric surgery. Cautious decision-making in these patients is warranted.

  6. Terroni, Lorenza

    1. Severe cutaneous reaction induced by allopurinol
      Pietro Bocchi, MD, Lorenza Terroni, MD and Corrado Pattacini, MD
      Cleveland Clinic Journal of Medicine June 2025, 92 (6) 331-333; DOI: https://doi.org/10.3949/ccjm.92a.24063

      Three weeks after starting allopurinol for gout, an 86-year-old woman presented with a maculopapular rash and painful blistering and erosions of the oral mucosa.

  7. Volk, Maximilian C.

    1. High-output heart failure from arteriovenous dialysis access: A structured approach to diagnosis and management
      Maximilian C. Volk, DO, Bianca Honnekeri, MD, Joanna Ghobrial, MD, Mazen Hanna, MD, Sanjeeb Bhattacharya, MD, Lee Kirksey, MD, J. Emanuel Finet, MD and Heba Wassif, MD, MPH
      Cleveland Clinic Journal of Medicine June 2025, 92 (6) 362-371; DOI: https://doi.org/10.3949/ccjm.92a.24114

      Arteriovenous high-output heart failure is likely underdiagnosed because many clinicians are uncertain about when and how to evaluate for it.

  8. Wassif, Heba

    1. High-output heart failure from arteriovenous dialysis access: A structured approach to diagnosis and management
      Maximilian C. Volk, DO, Bianca Honnekeri, MD, Joanna Ghobrial, MD, Mazen Hanna, MD, Sanjeeb Bhattacharya, MD, Lee Kirksey, MD, J. Emanuel Finet, MD and Heba Wassif, MD, MPH
      Cleveland Clinic Journal of Medicine June 2025, 92 (6) 362-371; DOI: https://doi.org/10.3949/ccjm.92a.24114

      Arteriovenous high-output heart failure is likely underdiagnosed because many clinicians are uncertain about when and how to evaluate for it.

« Previous (Pages : 1 2 3 ... 3)next »
Back to top

In this issue